Physician profile
David M Colvard
NPI 1457459810
$12,222.40
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,513 · 2020: $2,180 · 2021: $2,948 · 2022: $2,950 · 2023: $446 · 2024: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $631.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oasis Medical, INC. | $9,902.42 | 2019-2022 | |
| Alcon Vision LLC | $695.37 | 2019-2023 | Acrysof Iq Vivity, Rocklatan |
| Sun Pharmaceutical Industries INC. | $308.97 | 2019-2023 | Cequa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $216.03 | 2019-2021 | |
| Glaukos Corporation | $140.49 | 2019 | |
| Bausch & Lomb Americas INC. | $125.00 | 2024 | Miebo, Xiidra |
| Ivantis, INC | $123.56 | 2019 | |
| Novartis Pharmaceuticals Corporation | $103.67 | 2019-2022 | |
| Abbvie INC. | $69.68 | 2022-2023 | Durysta |
| Shire North American Group INC | $63.08 | 2019 | |
| Allergan, INC. | $62.27 | 2020-2021 | |
| New World Medical,INC. | $56.01 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $54.69 | 2020-2021 | |
| Optos, INC. | $38.00 | 2022 | |
| Oyster Point Pharma, INC. | $35.83 | 2022-2024 | Tyrvaya |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thea Pharma INC. | $34.37 | 2023-2024 | Iyuzeh |
| Dompe US, INC. | $32.93 | 2022 | |
| Sight Sciences, INC. | $29.51 | 2019-2023 | Omni Surgical System |
| Eyevance Pharmaceuticals LLC | $28.10 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $28.09 | 2024 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $19.65 | 2019 | |
| Ocular Therapeutix, INC. | $16.10 | 2022 | |
| Omeros Corporation | $13.62 | 2020 | |
| Horizon Therapeutics Plc | $13.37 | 2022 | |
| Eyepoint US, INC. | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Colvard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.